Transdermal delivery refers to the administration of therapeutic agents through the skin to achieve systemic effects. This method bypasses both the digestive system and first-pass metabolism, allowing for direct and efficient entry into the bloodstream.
NON-INVASIVE: Avoids stress and trauma associated with other administration routes.
CONTINUOUS RELEASE: Provides consistent and prolonged therapeutic levels.
STREAMLINED ABSORPTION: Skips the digestive system, minimizing potential stomach discomfort and interference with oral medications while also avoiding first-pass metabolism.
– Pain management
– Behavior modification
– Hormonal therapies
Organogels are semi-solid systems in which an organic liquid phase is gelled by a network of an organogelator. They have shown:
ENHANCED SKIN PENETRATION: Zoeuticals’ organogel transdermal delivery system leverages organic ingredients combined with advanced penetration techniques to navigate the stratum corneum barriers, facilitating deeper permeation into the dermis.
ENHANCED BIOAVAILABILITY: Organogels can increase the amount of therapeutic agent available for absorption, leading to improved efficacy.
OPTIMIZED ABSORPTION DYNAMICS: Zoeuticals’ organogels enhance swift and comprehensive uptake through canine skin, maximizing therapeutic outcomes. This process aids in the efficient transfer of compounds from cutaneous microcirculation directly into the systemic flow.
ENHANCED PET COMPLIANCE: Zoeuticals’ transdermal organogel formulation ensures convenience for both pet owners and their pets, requiring fewer doses and boasting a high tolerance level.